We are live on ! Find out more
MC

Martin Currie Portfolio holdings

AUM $2.61B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
+3.96%
1 Year Est. Return
+29.41%
3 Year Est. Return
+113.59%
5 Year Est. Return
+146.61%
10 Year Est. Return
+447.23%
AUM
$1.17B
AUM Growth
+$2.22M
Cap. Flow
-$30.7M
Cap. Flow %
-2.63%
Top 10 Hldgs %
36.75%
Holding
92
New
10
Increased
31
Reduced
38
Closed
4

Top Buys

Rank Stock Value
1
BMO icon
Bank of Montreal
BMO
+$17M
2
SU icon
Suncor Energy
SU
+$9.3M
3
M icon
Macy's
M
+$9.01M
4
CCI icon
Crown Castle
CCI
+$6.91M
5
CZZ
Cosan Limited
CZZ
+$5.9M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$12.4M
2
EBAY icon
eBay
EBAY
+$10.2M
3
CHKP icon
Check Point Software Technologies
CHKP
+$8.62M
4
PX
Praxair Inc
PX
+$8.57M
5
BHI
Baker Hughes
BHI
+$6.08M

Sector Composition

Rank Sector Weight
1 Technology 22.76%
2 Financials 13.94%
3 Healthcare 13.14%
4 Energy 9.75%
5 Communication Services 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INFY icon
1
Infosys
INFY
$48.4B
$74.2M 6.37%
9,432,000
-112,000
-1% -$907K
CTSH icon
2
Cognizant
CTSH
$24.3B
$58.1M 4.99%
1,103,243
-7,251
-0.7% -$362K
TSM icon
3
TSMC
TSM
$2.09T
$43.9M 3.77%
1,960,671
-36,804
-2% -$802K
BAP icon
4
Credicorp
BAP
$32B
$43.7M 3.75%
272,552
+19,056
+8% +$3.03M
CVX icon
5
Chevron
CVX
$383B
$40.6M 3.48%
361,751
-11,599
-3% -$1.32M
VZ icon
6
Verizon
VZ
$193B
$37.9M 3.26%
811,197
-36,303
-4% -$1.78M
PFE icon
7
Pfizer
PFE
$142B
$33M 2.83%
1,116,304
+8,537
+0.8% +$245K
PM icon
8
Philip Morris
PM
$299B
$32.6M 2.8%
400,380
-16,390
-4% -$1.41M
ABBV icon
9
AbbVie
ABBV
$455B
$32.6M 2.8%
498,250
-197,050
-28% -$12.4M
AAPL icon
10
Apple
AAPL
$4.9T
$31.7M 2.72%
1,150,204
-37,600
-3% -$1.02M
KMI icon
11
Kinder Morgan
KMI
$70.5B
$31.3M 2.68%
738,991
+70,200
+10% +$2.76M
EWT icon
12
iShares MSCI Taiwan ETF
EWT
$9.6B
$30.6M 2.62%
1,011,650
PG icon
13
Procter & Gamble
PG
$335B
$29.3M 2.51%
321,118
-23,582
-7% -$2.07M
SRE icon
14
Sempra
SRE
$58.6B
$28.9M 2.48%
519,024
+7,200
+1% +$392K
CVS icon
15
CVS Health
CVS
$134B
$27.2M 2.34%
282,874
-31,922
-10% -$2.81M
JPM icon
16
JPMorgan Chase
JPM
$933B
$25.6M 2.2%
408,788
+8,500
+2% +$512K
INDA icon
17
iShares MSCI India ETF
INDA
$6.88B
$20M 1.72%
668,200
-110,500
-14% -$3.41M
BBWI icon
18
Bath & Body Works
BBWI
$4.02B
$19.8M 1.7%
283,369
-35,873
-11% -$2.21M
AIG icon
19
American International
AIG
$41.8B
$19.3M 1.66%
344,460
-15,340
-4% -$823K
RTX icon
20
RTX Corp
RTX
$289B
$18.2M 1.56%
250,822
-33,193
-12% -$2.26M
PNC icon
21
PNC Financial Services
PNC
$99.2B
$17.7M 1.52%
193,568
-14,727
-7% -$1.28M
BSAC icon
22
Banco Santander Chile
BSAC
$16.5B
$17.6M 1.51%
891,273
+16,200
+2% +$345K
MSFT icon
23
Microsoft
MSFT
$3.35T
$17.3M 1.49%
372,708
+21,800
+6% +$1.02M
BMO icon
24
Bank of Montreal
BMO
$125B
$16.8M 1.44%
+237,000
New +$17M
LYB icon
25
LyondellBasell Industries
LYB
$19.5B
$15.7M 1.35%
197,973
-6,900
-3% -$598K

Similar funds

Martin Currie's Q4 2014 Portfolio in Review

As of Q4 2014, Martin Currie held 92 positions worth $1.17B, up 0.19% from $1.16B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Martin Currie's Q4 2014 filing shows 10 new, 31 increased, 38 reduced and 4 closed positions. Its largest new stake was Bank of Montreal: 237,000 shares worth $16.8M. The largest sale was AbbVie, an estimated $12.4M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Martin Currie's largest Q4 2014 buy was Bank of Montreal: 237,000 shares worth $16.8M.
  • Martin Currie added most to Crown Castle in Q4 2014, an estimated $6.91M increase.
  • Martin Currie's biggest Q4 2014 reduction was AbbVie, cutting an estimated $12.4M.
  • Martin Currie fully exited Ansys in Q4 2014, selling an estimated $4.73M.
  • Martin Currie's ten largest holdings make up 37% of its $1.17B portfolio in Q4 2014.
  • Martin Currie opened 10 new positions and closed 4 in Q4 2014.
  • Martin Currie's portfolio value rose 0.19% quarter-over-quarter to $1.17B.

Based on Martin Currie's 13F filing for Q4 2014, filed 17 Feb 2015.